Department of Medical Sociology and Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Health Econ. 2014 Feb;23(2):141-58. doi: 10.1002/hec.2909. Epub 2013 Jan 28.
The International AIDS Vaccine Initiative recommends targeting resources to research institutions in developing countries in order to accelerate the development of an effective HIV vaccine. In contrast, this paper shows that neither lump-sum nor in-kind transfers are an effective policy. We analyze several financing mechanisms as a means to overcome the lack of depth in HIV-vaccine research in a non-cooperative framework. At first, we point to cases in which financial support is actually counterproductive. Then we analyze whether in-kind transfers are preferable to lump-sum transfers. Even if donors prefer aid in kind because the incentives for moral hazard of recipients can be reduced, we demonstrate that it is effective only if recipients have cost advantages.
国际艾滋病疫苗倡议组织建议将资源集中投向发展中国家的研究机构，以加速有效艾滋病毒疫苗的研发。相比之下，本文表明，无论是整笔赠款还是实物捐赠都不是有效的政策。我们分析了几种融资机制，以在非合作框架下克服艾滋病毒疫苗研究深度不足的问题。首先，我们指出了财政支持实际上适得其反的情况。然后我们分析了实物捐赠是否优于整笔赠款。即使捐赠方因为可以降低受援方道德风险的激励而更倾向于实物援助，我们也证明，只有在受援方具有成本优势的情况下，这种援助才是有效的。
